Florida Resident Sues Prinston Pharmaceutical for Presence of Carcinogens
in Over-the-Counter Blood Pressure Medication
On October 25, 2018, Florida resident Ron Molinaro filed a complaint against
Prinston Pharmaceutical Inc., Solco Healthcare LLC, Solco Healthcare U.S.
LLC, and Huahai US Inc. in the U.S. District Court of the Middle District
of Florida. Molinaro alleged that the generic blood pressure medication
he bought (Valsartan-Hydrochlorothiazide) contained a potentially carcinogenic
substance (N-nitrosodimethylamine) due to mistakes made during the drug
manufacturing process. By filing a product liability lawsuit against the
aforementioned parties, Molinaro aims to recover damages, punitive damages,
restitution, and/or injunctive relief for the harmful conduct of the pharmaceutical
According to the plaintiff, the Valsartan medications created by the named
pharmaceutical companies failed to conform to their warranties and representations
of the product due to the fact that it was not created in a manner compliant
with current manufacturing regulations. Molinaro also alleges that, as
a result, the Valsartan products he used were adulterated.
Valsartan Lawyers Serving Clients Nationwide
At Golomb & Honik, P.C., we serve clients throughout the United States
who have been negatively affected by the unsafe, harmful practices of
pharmaceutical manufacturers. We are currently representing Mr. Molinaro,
and we are pleased to play a central role in holding pharmaceutical companies
responsible for their negligence, especially when it causes harm to consumers.
If you have been harmed due to a dangerous medication, we may be able to
review your case and help you evaluate your options. Evidence of a pharmaceutical
manufacturer’s liability in your case could allow you to recover
compensation for related expenses, such as medical care, lost wages, etc.
Connect with a member of our team today to speak to a
national dangerous drug attorney.
Call (215) 278-4449 today to schedule your free, no-obligation consultation.